Apolipoprotein H induces sex-specific steatohepatitis and gut dysbiosis during chronic hepatitis B infection

[1]  Zhe Wu,et al.  Alcohol-dependent downregulation of apolipoprotein H exacerbates fatty liver and gut microbiota dysbiosis in mice , 2022, Lipids in Health and Disease.

[2]  Han-Na Kim,et al.  Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B , 2021, Gut Pathogens.

[3]  E. Chang,et al.  Gut microbiota as a transducer of dietary cues to regulate host circadian rhythms and metabolism , 2021, Nature Reviews Gastroenterology & Hepatology.

[4]  O. Lushchak,et al.  Sex differences in the phylum‐level human gut microbiota composition , 2021, BMC microbiology.

[5]  Nayoung Kim,et al.  Roles of Sex Hormones and Gender in the Gut Microbiota , 2021, Journal of neurogastroenterology and motility.

[6]  P. Puri,et al.  Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease. , 2021, Translational gastroenterology and hepatology.

[7]  B. Guleng,et al.  Apolipoprotein H drives hepatitis B surface antigen retention and endoplasmic reticulum stress during hepatitis B virus infection. , 2020, The international journal of biochemistry & cell biology.

[8]  R. Knight,et al.  Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease. , 2020, Cell metabolism.

[9]  K. Clément,et al.  Metabolism and Metabolic Disorders and the Microbiome: The intestinal microbiota associated with obesity, lipid metabolism and metabolic health: pathophysiology and therapeutic strategies. , 2020, Gastroenterology.

[10]  M. Yuen,et al.  Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance. , 2020, Journal of hepatology.

[11]  M. Yuen,et al.  Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B. , 2020, Journal of hepatology.

[12]  M. Kumar,et al.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission , 2019, The Lancet Gastroenterology & Hepatology.

[13]  Haiming Hu,et al.  Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives , 2019, Journal of Gastroenterology.

[14]  Gregory J. Gores,et al.  A global view of hepatocellular carcinoma: trends, risk, prevention and management , 2019, Nature Reviews Gastroenterology & Hepatology.

[15]  T. Hassanein,et al.  The Effects of Hepatic Steatosis on the Natural History of HBV Infection. , 2019, Clinics in liver disease.

[16]  D. J. Kim,et al.  Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease , 2019, Expert review of gastroenterology & hepatology.

[17]  Hongbing Shen,et al.  Hepatitis B virus infection and risk of non‐alcoholic fatty liver disease: A population‐based cohort study , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[18]  S. Anticoli,et al.  Sex-Dependent Outcome of Hepatitis B and C Viruses Infections: Synergy of Sex Hormones and Immune Responses? , 2018, Front. Immunol..

[19]  N. Trehanpati,et al.  Fatty liver checkmates hepatitis B virus , 2018, Hepatology International.

[20]  S. Kottilil,et al.  Chronic Hepatitis B Infection: A Review , 2018, JAMA.

[21]  S. Nagini,et al.  Cytochrome P450 Structure, Function and Clinical Significance: A Review. , 2018, Current drug targets.

[22]  Thomas Berg,et al.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.

[23]  R. Klein,et al.  Sex Drives Dimorphic Immune Responses to Viral Infections , 2017, The Journal of Immunology.

[24]  H. Ellerbrok,et al.  Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the Virus , 2015, PloS one.

[25]  Hui Li,et al.  Association of the Trp316Ser variant (rs1801690) near the apolipoprotein H (β2-glycoprotein-I) gene and serum lipid levels. , 2015, International journal of clinical and experimental pathology.

[26]  Zhongfeng Wang,et al.  High expression of beta2‐glycoprotein I is associated significantly with the earliest stages of hepatitis B virus infection , 2014, Journal of medical virology.

[27]  F. Veas,et al.  Apolipoprotein H, an Acute Phase Protein, a Performing Tool for Ultra-Sensitive Detection and Isolation of Microorganisms from Different Origins , 2011 .

[28]  W. Miller,et al.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. , 2011, Endocrine reviews.

[29]  P. D. de Groot,et al.  Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. , 2010, Blood.

[30]  P. Lenting,et al.  Interaction of beta2-Glycoprotein I with Members of the Low Density Lipoprotein Receptor Family. , 2005 .

[31]  A. Naqvi,et al.  A hydrophobic sequence at position 313-316 (Leu-Ala-Phe-Trp) in the fifth domain of apolipoprotein H (beta2-glycoprotein I) is crucial for cardiolipin binding. , 2000, European journal of biochemistry.

[32]  R. Hamman,et al.  Molecular basis of the apolipoprotein H (beta 2-glycoprotein I) protein polymorphism. , 1997, Human Genetics.

[33]  F. Veglia,et al.  Influence of apolipoprotein H polymorphism on levels of triglycerides. , 1994, Atherosclerosis.

[34]  K. Sutherland,et al.  Hepatitis B virus surface antigen binds to apolipoprotein H , 1994, Journal of virology.